CINECA IRIS Institutional Research Information System

CORSINI, GIOVANNI UMBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.229
EU - Europa 9.846
AS - Asia 7.144
SA - Sud America 861
AF - Africa 234
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 5
Totale 34.334
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.497
PL - Polonia 4.307
CA - Canada 2.640
CN - Cina 2.447
SG - Singapore 2.100
IT - Italia 1.472
SE - Svezia 1.004
HK - Hong Kong 917
GB - Regno Unito 769
BR - Brasile 720
KR - Corea 548
BG - Bulgaria 495
UA - Ucraina 458
DE - Germania 416
TR - Turchia 340
FI - Finlandia 290
VN - Vietnam 254
RU - Federazione Russa 235
CH - Svizzera 160
IN - India 138
BD - Bangladesh 86
CI - Costa d'Avorio 80
FR - Francia 80
JP - Giappone 74
AR - Argentina 46
IQ - Iraq 40
MX - Messico 33
SA - Arabia Saudita 32
BE - Belgio 31
VE - Venezuela 29
ZA - Sudafrica 28
SN - Senegal 26
KE - Kenya 21
UZ - Uzbekistan 21
EC - Ecuador 20
ES - Italia 19
NL - Olanda 19
PK - Pakistan 19
MA - Marocco 16
AT - Austria 15
IL - Israele 14
TN - Tunisia 14
AE - Emirati Arabi Uniti 13
GR - Grecia 13
BB - Barbados 11
CO - Colombia 11
JO - Giordania 11
NG - Nigeria 11
CZ - Repubblica Ceca 10
ID - Indonesia 10
IE - Irlanda 10
JM - Giamaica 10
KZ - Kazakistan 10
PY - Paraguay 10
QA - Qatar 10
TT - Trinidad e Tobago 9
UY - Uruguay 9
BJ - Benin 8
NP - Nepal 8
PE - Perù 8
AL - Albania 7
AU - Australia 7
AZ - Azerbaigian 7
CR - Costa Rica 7
MY - Malesia 7
NZ - Nuova Zelanda 7
OM - Oman 7
EG - Egitto 6
LB - Libano 6
DZ - Algeria 5
HU - Ungheria 5
EE - Estonia 4
ET - Etiopia 4
HN - Honduras 4
PH - Filippine 4
CL - Cile 3
EU - Europa 3
KG - Kirghizistan 3
LT - Lituania 3
MD - Moldavia 3
PS - Palestinian Territory 3
PT - Portogallo 3
RO - Romania 3
AG - Antigua e Barbuda 2
AM - Armenia 2
BF - Burkina Faso 2
BO - Bolivia 2
BS - Bahamas 2
BZ - Belize 2
GE - Georgia 2
GH - Ghana 2
HR - Croazia 2
JE - Jersey 2
LV - Lettonia 2
LY - Libia 2
NI - Nicaragua 2
PA - Panama 2
PR - Porto Rico 2
RS - Serbia 2
SR - Suriname 2
Totale 34.297
Salva come PNG Salva come JPEG
Città #
Montreal 2.304
Woodbridge 1.390
Ashburn 1.330
Singapore 1.179
Fairfield 1.177
Ann Arbor 1.081
Houston 1.007
Chandler 947
Hong Kong 908
Hefei 746
Santa Clara 684
Jacksonville 589
Milan 552
Seoul 540
Seattle 533
Sofia 494
Dallas 492
Cambridge 418
Wilmington 410
Beijing 405
Lancaster 391
Shanghai 369
New York 303
Ottawa 286
Izmir 227
Los Angeles 207
Boardman 205
Nanjing 196
Princeton 193
Lawrence 187
Medford 172
Bern 157
Serra 132
Des Moines 130
Dearborn 128
Buffalo 125
Jüchen 100
London 96
Istanbul 93
Nanchang 93
Dong Ket 88
Abidjan 80
Chicago 77
Tokyo 66
São Paulo 65
San Diego 56
Redondo Beach 47
Kunming 45
Ogden 45
Redwood City 45
Rome 44
Boulder 40
Frankfurt am Main 38
Columbus 35
Munich 34
The Dalles 32
Brussels 31
Norwalk 30
Florence 29
Pune 29
Council Bluffs 27
Shenyang 27
Bremen 26
Changsha 26
Dakar 26
Düsseldorf 26
Rio de Janeiro 26
Hebei 25
Tianjin 23
Falls Church 22
Verona 21
Dhaka 20
Tashkent 20
Nairobi 19
Guangzhou 18
Jiaxing 18
Orange 18
Phoenix 18
Turku 18
Helsinki 16
Belo Horizonte 15
Riyadh 14
Washington 14
Baghdad 13
Fuzhou 13
Grafing 13
Paris 13
Pisa 12
Amman 11
Auburn Hills 11
Boston 11
Bridgetown 11
Johannesburg 11
Quanzhou 11
San Francisco 11
Warsaw 11
Detroit 10
Doha 10
Hanoi 10
Lanzhou 10
Totale 22.607
Salva come PNG Salva come JPEG
Nome #
Parkinsonism by MPTP in mice: a model for regenerative processes of nigrostriatal dopaminergic pathway 3.449
MPTP FAILS TO INDUCE LIPID-PEROXIDATION INVIVO 2.083
PARKINSONS-DISEASE AND PESTICIDES 1.185
HIGH-AFFINITY BINDING-SITES FOR 1-METHYL-4-PHENYL-PYRIDINIUM ION (MPP+) ARE PRESENT IN MOUSE-BRAIN 531
[H-3] 1-METHYL-4-PHENYL-2,3-DIHYDROPYRIDINIUM ION BINDING-SITES IN MOUSE-BRAIN - PHARMACOLOGICAL AND BIOLOGICAL CHARACTERIZATION 237
Pharmacological manipulation of embryonic dopaminergic neurons implanted in adult mouse striatum: a new therapeutical approach to Parkinson’s disease. 235
G protein-linked receptors: pharmacological evidence for the formation of heterodimers 235
Characterization of the Engrailed mutant mice as experimental models for Parkinson's disease 231
Embryonic neural grafts induce recovery in mice with permanent striatal lesion 217
Partial agonist actions at dopamine D2L receptors are modified by co-transfection of D3 receptors: potential role of heterodimer formation 217
Bright light exposure reduces TH-positive dopamine neurons: implications of light pollution in Parkinson's disease epidemiology. 213
Ethanol intake and ethanol-induced locomotion and locomotor sensitization in CYP2E1 knockout mice 212
(+)MK-801 PREVENTS THE DDC-INDUCED ENHANCEMENT OF MPTP TOXICITY IN MICE 212
Localization of a glutathione-dependent dehydroascorbate reductase within the central nervous system of the rat 212
D-1 AND D-2 DOPAMINE SYSTEM INTERACTIONS IN THE MPTP-LESIONED MONKEY 209
INCREASED PAROXYSMAL ACTIVITY OF PARTIAL SEIZURES IN MAN BY APOMORPHINE 201
Assessing neuroprotection in Parkinson's disease: from the animal models to molecular neuroimaging in vivo 199
Pharmacological modulation of regenerative processes aftar nigrostriatal dopaminergic lesion: a new therapeutical approach to Parkinson’s disease 198
Clozapine as the most efficacious antipsychotic for activating ERK 1/2 kinases: Role of 5-HT2A receptor agonism 198
Fluorescent light induces neurodegeneration in the rodent nigrostriatal system but near infrared LED light does not 198
Partial agonist actions of aripiprazole and the candidate antipsychotics S33592, bifeprunox, N-desmethylclozapine and preclamol at dopamine D(2L) receptors are modified by co-transfection of D(3) receptors: potential role of heterodimer formation 197
Involvement of cytochrome P450 2E1 in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease 195
Apomorphine offers new insight into dopaminergic neuron vulnerability in mesencephalic cultures 195
Region- and neurotransmitter-dependent species and strain differences in DSP-4-induced monoamine depletion in rodents. 194
EVIDENCE FOR DOPAMINE RECEPTORS IN HUMAN-BRAIN MEDIATING SEDATION AND SLEEP 192
1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE - CORRESPONDENCE OF ITS BINDING-SITES TO MONOAMINE-OXIDASE IN RAT-BRAIN, AND INHIBITION OF DOPAMINE OXIDATIVE DEAMINATION INVIVO AND INVITRO 191
COVALENT BINDING AS A BIOCHEMICAL MECHANISM FOR TOXICITIES COVALENT BINDING OF STILBENE (ST) AND DIETHYLSTILBESTROL (DES) TO LIVER-MICROSOMES 190
TSH-Dependent Expression of the LDL Receptor-Associated Protein (RAP) in Thyroid Epithelial Cells 190
DEPRENYL SELECTIVELY INHIBITS [H-3] MPTP BINDING-SITES IN MONKEY BRAIN 189
HIGH-AFFINITY BINDING OF [H-1]1-METHYL-4-PHENYL-2,3-DIHYDROPYRIDINIUM ION TO MOUSE STRIATAL MEMBRANES - PUTATIVE VESICULAR LOCATION 189
MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates. 187
Pharmacologic modulation of MPTP toxicity: MK 801 in prevention of dopaminergic cell death in monkeys and mice. 187
Serotonin abnormalities in engrailed-2 knockout mice: new insight relevant for a model of autism spectrum disorder 186
EFFECTS OF BIGUANIDES ON FATTY-ACID AND GLUCOSE OXIDATION IN MUSCLE 183
SELECTIVE INCREASE OF BRAIN DOPAMINE SYNTHESIS BY SULPIRIDE 181
Role of CYP2E1 in the mouse model of MPTP toxicity 181
Acetaldehyde and parkinsonism: role of CYP450 2E1. 180
INHIBITION OF [H-3] MPTP BINDING TO RAT-BRAIN BY PARGYLINE 178
Clonidine prevents while yohimbine enhances MPTP toxicity in mice. 178
Behavioral, Neurochemical, and Electrophysiological Changes in an Early Spontaneous Mouse Model of Nigrostriatal Degeneration 178
APOMORPHINE HYDROCHLORIDE-INDUCED IMPROVEMENT IN HUNTINGTONS-CHOREA - STIMULATION OF DOPAMINE RECEPTOR 177
MPTP TREATMENT COMBINED WITH ETHANOL OR ACETALDEHYDE SELECTIVELY DESTROYS DOPAMINERGIC-NEURONS IN MOUSE SUBSTANTIA NIGRA 177
Revealing G-protein-coupled receptor oligomerization at the single-molecule level through a nanoscopic lens: Methods, dynamics and biological function 177
Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors. 177
Cytochrome P450 and Parkinson's disease: protective role of neuronal CYP 2E1 from MPTP toxicity 176
CYP 2E1 mutant mice are resistant to DDC-induced enhancement of MPTP toxicity 175
Modulation of dihydroxyphenylacetaldehyde extracellular levels in vivo in the rat striatum after different kinds of pharmacological treatment 174
MPTP-induced model of Parkinson's disease in cytochrome P450 2E1 knockout mice 174
Sodium nitroprusside induces internalization of muscarinic receptors stably expressed in Chinese hamster ovary cell lines 172
METOCLOPRAMIDE AND DYSTONIC REACTIONS IN SARDINIANS 172
From dopamine metabolism to Parkinson’s disease. 172
Effect of metadoxine on striatal dopamine levels in C57 black mice 172
Increased susceptibility to kainic acid-induced seizures in Engrailed-2 knockout mice. 172
SPECIFIC REINNERVATION OF LESIONED MOUSE STRIATUM BY GRAFTED MESENCEPHALIC DOPAMINERGIC-NEURONS 171
Effects of Pretreatment with N-(2-Chloroethyl)-N- Ethyl-2-Bromobenzylamine (DSP-4) of Methamphetamine Pharmacokinetics and Striatal Dopamine losses 171
Apomorphine has a potent antiproliferative effect on Chinese hamster ovary cells 171
EFFECT OF APOMORPHINE ON HUMAN SLEEP 170
DECREASED CONVERSION OF TYROSINE TO CATECHOLAMINES IN BRAIN OF RATS TREATED WITH PARA CHLOROPHENYLALANINE 169
PROPERTIES OF BENZODIAZEPINE BINDING-SITES IN PERIPHERAL-TISSUES 169
DOPAMINERGIC MECHANISMS IN HEMIPARKINSONIAN MONKEYS 169
Identification and determination of 3,4-dihydroxyphenylacetaldehyde, the dopamine metabolite in in vivo dialysate from rat striatum. 169
Pharmacological modulation of regenerative processes after nigrostriatal dopaminergic lesion: A new therapeutical approach to Parkinson's disease 169
THERAPEUTIC EFFICACY OF APOMORPHINE COMBINED WITH AN EXTRA-CEREBRAL INHIBITOR OF DOPAMINE RECEPTORS IN PARKINSONS-DISEASE 168
ACETALDEHYDE DIRECTLY ENHANCES MPP+ NEUROTOXICITY AND DELAYS ITS ELIMINATION FROM THE STRIATUM 168
INHIBITION OF NITRIC-OXIDE SYNTHASE DRAMATICALLY POTENTIATES SEIZURES INDUCED BY KAINIC ACID AND PILOCARPINE IN RATS 168
Functional role of the third cytoplasmic loop in muscarinic receptor dimerization. 168
EFFECT OF ORAL-ADMINISTRATION OF TRYPTOPHAN-FREE AMINO-ACID MIXTURES ON SERUM TRYPTOPHAN, BRAIN TRYPTOPHAN AND SEROTONIN METABOLISM 166
MODULATION OF DOPAMINE AGONIST ACTION BY ESTROGENS 166
DOMPERIDONE AND APOMORPHINE IN HUNTINGTONS-CHOREA 166
PHARMACOLOGICAL MANIPULATION OF EMBRYONIC DOPAMINERGIC-NEURONS IMPLANTED IN ADULT-MOUSE STRIATUM - A NEW THERAPEUTIC APPROACH TO PARKINSONS-DISEASE 166
An unusual form of the association binding kinetics of N-[ [H-3] methylscopolamine to the split muscarinic M-2trunk/M-2tail receptor 166
PARKINSONISM BY HALOPERIDOL AND PIRIBEDIL 163
DOPAMINE AGONISTS IN THE TREATMENT OF SCHIZOPHRENIA 163
Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences 163
Biochemestry of experimental parkinsonism. 162
Nicotine prevents experimental parkinsonism in rodents. 161
Norepinephrine loss selectively enhances chronic nigrostriatal dopamine depletion in mice and rats 161
CHARACTERIZATION OF A PUTATIVELY VESICULAR BINDING-SITE FOR [H-3] MPP+ IN MOUSE STRIATAL MEMBRANES 159
Dopamine agonists and analogues have an antiproliferative effect on CHO-K1 cells 159
Long-term treatment of bipolar disorder:how should we use lithium salts? 159
Is lithium able to reverse neurological damage induced by vinca alkaloids? 158
Molecular and cellular events regulating dopamine survival 156
Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism. 156
Dose-dependent induction of apoptosis by R-apomorphine in CHO-K 1 cell line in culture 156
PHARMACOLOGICAL MODULATION OF DEVELOPMENT AND PLASTICITY IN NIGRO-STRIATAL DOPAMINERGIC-NEURONS 156
Antagonist binding profile of the split chimeric muscarinic m2-trunc/m3-tail receptor 155
ROLE OF H-3 MPP+ BINDING-SITES IN THE MPTP NEUROTOXICITY USING QUANTITATIVE AUTORADIOGRAPHY 154
Mk-801 previene la degenerazione dei neuroni dopaminergici nigrostriatali indotta da MPTP: ruolo degli aminoacidi eccitatori nei processi di invecchiamento del sistema nigrostriatale. 153
Species differences in the role of excitatory amino acids in experimental parkinsonism. 153
Cytochrome p450 and parkinsonism: protective role of CYP2E1 153
Norepinephrine loss exacerbates methamphetamine-induced striatal dopamine depletion in mice 153
Involvment of excitatory aminoacids in MPTP toxicity 152
IN BROWN-NORWAY RATS, MPP(+) IS ACCUMULATED IN THE NIGROSTRIATAL DOPAMINERGIC TERMINALS BUT IT IS NOT NEUROTOXIC - A MODEL OF NATURAL-RESISTANCE TO MPTP TOXICITY 152
Noradrenergic modulation of methamphetamine-induced striatal dopamine depletion 149
TRYPTOPHAN-FREE DIETS - NEW MEANS FOR EFFECTIVELY DECREASING BRAIN-SEROTONIN SYNTHESIS IN ANIMALS AND MAN 146
Striatal MPP+ levels do not necessarily correlate with striatal dopamine levels after MPTP treatment in mice. 146
EVALUATION OF THE TOXICITY OF THE DOPAMINERGIC NEUROTOXINS MPTP AND MPP+ IN PC12 PHEOCHROMOCYTOMA CELLS - BINDING AND BIOLOGICAL STUDIES 145
MK801 prevents MPTP-induced dopaminergic cell death in monkeys and mice 143
(+) MK-801 PREVENTS DIETHYLDITHIOCARBAMATE-INDUCED NEURONAL DAMAGE 143
DEMONSTRATION OF MECHANISM OF ACTION OF BIGUANIDES 142
Totale 24.181
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.629
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.629
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.001 0 0 0 0 0 72 127 155 141 140 102 264
2021/20222.059 66 106 41 155 413 269 32 96 102 73 86 620
2022/20232.469 355 354 124 241 274 359 27 184 389 12 125 25
2023/20248.729 386 212 335 124 267 369 42 74 42 6.644 43 191
2024/20256.298 32 207 37 353 534 507 403 280 498 727 823 1.897
2025/20263.633 423 1.037 825 363 384 601 0 0 0 0 0 0
Totale 34.566